News

Plus, underuse of aspirin after stent is “a travesty” says Mayo doctor Cardiologists were urged to halt the "epidemic of madness" behind drug-eluting stent (DES) overuse, during an address by Salim Yusuf, M.D., McMaster University, Hamilton, Ontario, at the World Congress of Cardiology in Barcelona.

Home September 18, 2006
Home
News

Positive six-month results of Abbott's SPIRIT II clinical trial of the XIENCE V Everolimus Eluting Coronary Stent System were presented at the World Congress of Cardiology conference in Barcelona, Spain. XIENCE V, which has received CE Mark approval, is currently an investigational device in the U.S. and Japan — Abbott says it plans to initiate European launch of the coronary DES in October.

Home September 18, 2006
Home
News

Thousands of lives potentially saved and hospital costs reduced are the predicted outcomes if more hospitals adopt certain quality measures on a wider scale, according to an analysis by Premier Inc. healthcare alliance, headquartered in San Diego, which is owned by more than 200 of the nation's leading not-for-profit hospitals and healthcare systems.

Home September 18, 2006
Home
Feature | Ryan Hiett

It may seem like a simple concept, but the importance of properly controlled patient temperature is still surprising ...

Home September 12, 2006
Home
Technology

Abiomed Inc. recently announced the start of the IMPELLA 2.5 pilot study in the U.S. with the enrollment of the first ...

Home August 29, 2006
Home
Technology

A software fusion application that enables clinicians to perform multimodality image fusion in a single application ...

Home August 29, 2006
Home
Technology

OXILAN (Ioxilan Injection) is a contrast media for use in peripheral procedures because of its viscosity. Its reportedly ...

Home August 29, 2006
Home
Feature | Kim Phelan

At a pivotal time of advancement in cardiovascular imaging, diagnostics, interventions and therapies, a time when specialty heart hospitals are forming to combat the deadliest disease in America, the federal purse strings are about to be pulled a little tighter in 2007, and rules for these types of narrowly focused hospitals are going to be more stringent.

Home August 29, 2006
Home
Feature | Ryan Hiett

While enormous pressure may be the norm for cardiac surgeons, the stakes are particularly high when the life of a former U.S. president is on the line. And when Bill Clinton underwent quadruple bypass surgery in 2004, all eyes were on the heart specialists at NewYork-Presbyterian Hospital in New York City.

Home August 29, 2006
Home
Technology

The Relay 250-mm thoracic stent-graft is commercially available in Europe in both straight and taper configurations. The ...

Home August 29, 2006
Home
Technology

The EXCOR TAH-t has received CE approval with the CardioWest TAH-t. The pneumatic drivers provide precisely calibrated ...

Home August 29, 2006
Home
Technology

The Philips integrated cath lab is a solution featuring integrated technologies designed to improve productivity and throughput.

Home August 29, 2006
Home
Case Study | Kishor N. Vora, MD., Interventional Cardiologist, Owensboro Medical Health System, Owensboro, Kentuc

Targeted Renal Therapy (TRT) with the Benephit CV Infusion System from FlowMedica Inc. is an alternative to systemic intravenous (IV) infusion of medications to address kidney dysfunction related to a number of conditions. TRT is a novel technology that enables the infusion of medications and other therapeutic agents directly into the kidneys via the renal arteries.

Home August 29, 2006
Home
Technology

The Atlas II ICD (implantable cardioverter defibrillator) and Atlas II HF CRT-D (cardiac resynchronization therapy defibrillator) devices are capable of delivering unsurpassed energy, giving added security to patients whose hearts are especially difficult to defibrillate.

Home August 29, 2006
Home
Technology

The i-STAT BNP cartridge is a point of care diagnostic test used to assess the level of BNP (brain naturietic peptide) ...

Home August 29, 2006
Home
Subscribe Now